English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 13, 2026

GLP-1-induced weight loss linked to improved partnership and employment opportunities for women
+ Pharmaceuticals
Patient Daily | Jul 13, 2026

Researchers identify new therapy targeting Hippo pathway for resistant acute myeloid leukemia
+ Pharmaceuticals
Patient Daily | Jul 13, 2026

FDA posts new rejection letters after confirming temporary pause on disclosures
+ Pharmaceuticals
Patient Daily | Jul 13, 2026

ENT & Allergy Associates announces Sydney C. Butts, MD, to join Brooklyn office in September
+ Technology/Innovation
A. R. Adams | Jul 13, 2026

Mental health expert: Treatment-resistant depression often carries hidden costs in the workplace
+ Pharmaceuticals
Patient Daily | Jul 13, 2026

Study finds screen use to soothe children affects cognitive development in varied ways
+ Pharmaceuticals
Patient Daily | Jul 13, 2026

Study finds physicians follow AI errors despite contradictory patient outcomes
+ Pharmaceuticals
Patient Daily | Jul 13, 2026

FDA urged to include patient voices in rare disease advisory committees

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation